| Oct 05, 2010 |
Juvaris BioTherapeutics, Inc. announced that results from preclinical studies using its lead compound, JVRS-100, as an immunotherapy to treat acute myelogenous leukemia (AML) were published in the September edition of the journal Cancer Biology & Therapy. JVRS-100 has been shown to induce significant innate immunity resulting in anti-viral, anti-bacterial and anti-cancer effects... Read More
|
| Oct 05, 2010 |
Diagnostic X-rays may increase the risk of developing childhood leukemia, according to a new study by researchers at the University of California, Berkeley's School of Public Health. Specifically, the researchers found that children with acute lymphoid leukemia (ALL) had almost twice the chance of having been exposed to three or more X-rays compared with children who did not have leukemia... Read More
|
| Oct 05, 2010 |
As the song says, a spoonful of sugar helps the medicine go down, and now researchers at Johns Hopkins have found that the sights and sounds of chirping birds, ribbiting frogs and water trickling downstream can ease the substantial pain of bone marrow extraction in one of five people who must endure it... Read More
|
| Oct 05, 2010 |
James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr... Read More
|
| Oct 05, 2010 |
Mayo Clinic is making it easier for industry sponsors and investigators at sites across the country to collaborate with Mayo on complex and groundbreaking research studies and clinical trials... Read More
|
| Oct 05, 2010 |
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow... Read More
|
| Oct 05, 2010 |
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients. Also known as juvenile diabetes, type 1 diabetes is an autoimmune disease primarily affecting children and young adults... Read More
|
| Oct 05, 2010 |
Jefferson Radiology, the largest radiology private practice group in Connecticut, and U-Systems, the leader in automated breast ultrasound technology, announced the installation of the somo-v™ INSIGHT Class Automated Breast Ultrasound (ABUS) system. Jefferson Radiology is the first imaging center in Connecticut to add the new, state-of-the-industry, automated breast ultrasound capabilities... Read More
|
| Oct 05, 2010 |
Teva Pharmaceuticals Industries Ltd. (NASDAQ: TEVA) and OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC)... Read More
|
| Oct 05, 2010 |
ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced positive survival data from a Phase 2a clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. Median overall survival was 12.4 months, and the percentage of patients surviving at 12 months was 53%. "The median overall survival of 12... Read More
|
|
Previous Page
Next Page
|
